Literature DB >> 12450795

Transformation of normal human cells in the absence of telomerase activation.

Yvette R Seger1, Marta García-Cao, Sara Piccinin, Crocifissa Lo Cunsolo, Claudio Doglioni, María A Blasco, Gregory J Hannon, Roberta Maestro.   

Abstract

Our knowledge of the transformation process has emerged largely from studies of primary rodent cells and animal models. However, numerous attempts to transform human cells using oncogene combinations that are effective in rodents have proven unsuccessful. These findings strongly argue for the study of homologous experimental systems. Here we report that the combined expression of adenovirus E1A, Ha-RasV12, and MDM2 is sufficient to convert a normal human cell into a cancer cell. Notably, transformation did not require telomerase activation. Therefore, we provide evidence that activation of telomere maintenance strategies is not an obligate characteristic of tumorigenic human cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450795     DOI: 10.1016/s1535-6108(02)00183-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

1.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

3.  Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.

Authors:  Maurizio Mongiat; Giovanni Ligresti; Stefano Marastoni; Erica Lorenzon; Roberto Doliana; Alfonso Colombatti
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

Review 4.  How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.

Authors:  Yiming Lu; Bohua Wei; Tao Zhang; Zi Chen; Jing Ye
Journal:  Protein Cell       Date:  2013-07-18       Impact factor: 14.870

5.  Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc.

Authors:  Kathryn A Tworkowski; Abhishek A Chakraborty; Andrew V Samuelson; Yvette R Seger; Masako Narita; Gregory J Hannon; Scott W Lowe; William P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

6.  Deletions in the DNA-binding domain of the TP53 gene in v-src-transformed chicken cells.

Authors:  Katerina Trtková; Jirí Plachý
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

7.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 8.  Inflammatory signaling and cellular senescence.

Authors:  Jian-Lin Ren; Jin-Shui Pan; Ya-Pi Lu; Peiqing Sun; Jiahuai Han
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

9.  Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Chiara Del Buono; Fabrizio Stracci; Emanuele Cottini; Giovanni Cochetti; Vincenzo N Talesa; Ettore Mearini
Journal:  BMC Urol       Date:  2010-10-04       Impact factor: 2.264

10.  Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

Authors:  Orit Uziel; Einat Beery; Vladimir Dronichev; Katty Samocha; Sergei Gryaznov; Lola Weiss; Shimon Slavin; Michal Kushnir; Yardena Nordenberg; Claudette Rabinowitz; Baruch Rinkevich; Tania Zehavi; Meir Lahav
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.